WhatFinger
CFPSubcribe

Octava Pink, a groundbreaking achievement in cancer detection, follows eight years of research at EventusDx in Jerusalem.

Israelis develop first blood test for breast cancer


By Israel21c—— Bio and Archives--June 5, 2014

Lifestyles | Comments | Print Friendly | Subscribe | Email Us

After eight years of painstaking research, Israeli life-sciences company Eventus Diagnostics (EventusDx) has produced a blood test for the early detection of breast cancer.

The Octava Pink test is now available in Israel and Italy, and is undergoing clinical trials to receive US Food and Drug Administration approval.

This is the first blood test ever that can reveal cancer, not merely markers that might indicate cancer or something else. Its innovation also lies in its examination of antibodies in the blood to pinpoint this specific cancer.

Molecular biologist Galit Yahalom — who heads the research team at the EventusDx offices and lab, located in Moshav Ora outside of Jerusalem – explains the breakthrough to ISRAEL21c.

More…


Please SHARE this story as the only way for CFP to beat Facebook anti-Conservative Suppression.

Only YOU can save CFP from Social Media Suppression. Tweet, Post, Forward, Subscribe or Bookmark us

Guest Column Israel21c -- Bio and Archives | Comments

Items of notes and interest from the web.


Commenting Policy

Please adhere to our commenting policy to avoid being banned. As a privately owned website, we reserve the right to remove any comment and ban any user at any time.

Comments that contain spam, advertising, vulgarity, threats of violence and death, racism, anti-Semitism, or personal or abusive attacks on other users may be removed and result in a ban.
-- Follow these instructions on registering: